Dr. Daniel Bax

Dr Bax studied for his PhD in biochemistry as part of a CASE studentship with AstraZeneca Pharmaceuticals. He then joined the UK Centre for Tissue Engineering at the University of Manchester. There he researched the coating of polymers with biologically derived molecules (fibrillin-1) as a route to enhance their biocompatibility. He continued researching the interactions between materials and biologically derived molecules within a collaborative research position at the University of Sydney. In this position Dr Bax examined the orientation and molecular display of molecules such as tropoelastin adhering to plasma treated materials. From Sydney he returned to the UK to undertake a postdoctoral research position within the Cambridge Centre for Medical Materials (CCMM) examining the crosslinking of collagen based scaffolds. Dr Bax has recently obtained an EU funded Marie Curie International Incoming Fellowship to research collagen-elastin composites at the CCMM.